Here, we found nonsynonymous variants impacting AMELY, DDX3Y, RPS4Y2, and TBL1Y in five African tumors (4.7%), and UTY in a single European tumor (1.8%), highlighting the potential for these chrY genes as ancestry-specific cancer driver candidates. This evidence concerns the gene RPS4Y2 and cancer.